Endoscopic Metabolic and Bariatric Therapies
Launched by CHRISTOPHER C. THOMPSON, MD, MSC · Feb 10, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The Investigators will be collecting data on bariatric patients post-bariatric surgery, post-endoscopic revision of bariatric surgical complications and post-endoscopic metabolic and bariatric therapies (including but not limited to roux-en-y gastric bypass, sleeve gastrectomy, laparoscopic adjustable gastric banding, gastroplasty with endoscopic myotomy (GEM), endoscopic sleeve gastroplasty (ESG), transoral outlet reduction (TORe), primary obesity surgery endoluminal (POSE), restorative obesity surgery endoluminal (ROSE), intragastric balloons (IGB), aspiration therapy and pylorus sparing ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients from Mass General Brigham
- • any patient having an endoscopic primary obesity procedure
- • any patient having an endoscopic post-bariatric surgical revision procedure
- • any patient having a bariatric surgical procedure
- Exclusion Criteria:
- • patients without past surgical and medical history medical records in the Mass General Brigham system
- • patients unwilling to allow for medical record review at Mass General Brigham
About Christopher C. Thompson, Md, Msc
Christopher C. Thompson, MD, MSc, is a distinguished clinical trial sponsor renowned for his expertise in gastroenterology and advanced endoscopic techniques. With a robust academic background and a commitment to advancing medical research, Dr. Thompson leads innovative clinical trials aimed at improving patient outcomes in gastrointestinal disorders. His multidisciplinary approach, combined with a focus on evidence-based practices, ensures the integrity and efficacy of the trials he sponsors. Dr. Thompson's dedication to enhancing healthcare through rigorous research and collaboration positions him as a pivotal figure in the field of clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Christopher C. Thompson, MD, MSc
Principal Investigator
Brigham and Women's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials